Plymouth researchers awarded grant to evaluate pulmonary rehabilitation programme in East Africa

NewsGuard 100/100 Score

Chronic lung disease is a growing and debilitating health issue for countries in East Africa. Resulting from respiratory infections such as TB and HIV, and lifestyle problems such as tobacco smoking and poor nutrition, chronic lung disease affects one in five adults in Africa and is a major threat to health.

A research team from Plymouth University Peninsula Schools of Medicine and Dentistry has been awarded a grant in excess of £136,000 from the Medical Research Council/ Department for International Development/ Wellcome Trust Joint Global Health Trials scheme, to evaluate a pulmonary rehabilitation programme initially in Uganda.

As a development grant, if the evaluation is successful it will lead to the international roll-out of a larger evaluation trial which will incorporate centres in Uganda, Tanzania and Zambia.

Patients with chronic lung disease are prone to breathlessness and inactivity, and in Africa they are disproportionately from deprived communities, many lacking the means for drugs or transport to medical clinics.

The condition is having a negative impact on African economies through lost productivity and disability, and through additional pressure on already stretched health services - yet it is neglected as a health priority.

In a pilot study, the team established a pulmonary rehabilitation programme in Mulago, Uganda. The research team will assess the content of the programme and their ability to teach local health workers how to deliver it consistently.

The team will also test how inclusive the programme is for the local population, the number of patients who are suitable to take part in the programme and who are willing to take part, and ways to improve recruitment. They will also measure the effectiveness of the programme by analysing completion rates.

The team will then evaluate their findings, looking at effectiveness in measures such as walking distance and health status, as well as the programme's impact on social and economic factors.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Are we eating what's really good for us? New insights into macronutrients and chronic disease